Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials.

Felix BergmannLena PracherRebecca SawodnyAmelie BlaschkeGeorg Gelbenegger Christine Radtke Markus Zeitlinger Anselm Jorda

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)

Adjunctive systemic corticosteroid therapy in patients hospitalized with CAP was associated with a reduction in all-cause mortality by day 30. The benefits were more pronounced in patients with severe pneumonia.

Keyphrases

community acquired pneumonia
early onset
drug induced
intensive care unit
mechanical ventilation
acute respiratory distress syndrome